4d pharma (FRA:4DY) Interest Expense : €-0.72 Mil (TTM As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is 4d pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. 4d pharma's interest expense for the six months ended in Dec. 2021 was € -0.72 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2021 was €-0.72 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. 4d pharma's Operating Income for the six months ended in Dec. 2021 was € -15.70 Mil. 4d pharma's Interest Expense for the six months ended in Dec. 2021 was € -0.72 Mil. 4d pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

4d pharma Interest Expense Historical Data

The historical data trend for 4d pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Interest Expense Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-0.14

-0.61

-0.19

-0.72

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Interest Expense	Get a 7-Day Free Trial											-0.27	-0.10	-0.09	-	-0.72

4d pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.72 Mil.

4d pharma (FRA:4DY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

4d pharma's Interest Expense for the six months ended in Dec. 2021 was €-0.72 Mil. Its Operating Income for the six months ended in Dec. 2021 was €-15.70 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2021 was €11.59 Mil.

4d pharma's Interest Coverage for the quarter that ended in Dec. 2021 is calculated as

4d pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

4d pharma (FRA:4DY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (FRA:4DY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (FRA:4DY) Headlines

No Headlines